Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (SHE:300255)
China flag China · Delayed Price · Currency is CNY
48.73
+1.14 (2.40%)
Sep 8, 2025, 9:43 AM CST

SHE:300255 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 2016 - 2020
Operating Revenue
914.94997.771,3972,3272,9412,354
Upgrade
Other Revenue
39.733.0413.259.6527.39.76
Upgrade
954.641,0311,4102,3362,9682,364
Upgrade
Revenue Growth (YoY)
-17.55%-26.92%-39.63%-21.29%25.56%14.11%
Upgrade
Cost of Revenue
867.86937.351,7331,3151,246743.43
Upgrade
Gross Profit
86.7893.46-322.771,0211,7221,620
Upgrade
Selling, General & Admin
187.81216.34630.71739.691,2201,098
Upgrade
Research & Development
43.7547.19158.82145.01150.63127.54
Upgrade
Other Operating Expenses
29.512.1117.2422.0226.7723.71
Upgrade
Operating Expenses
262.64272.24822.15913.231,3981,252
Upgrade
Operating Income
-175.86-178.78-1,145107.99324.06368.78
Upgrade
Interest Expense
-105.13-102.83-96.41-93.04-62.29-55.81
Upgrade
Interest & Investment Income
36.4337.021.851.991.31.64
Upgrade
Currency Exchange Gain (Loss)
7.040.254.766.69-4.4-6.47
Upgrade
Other Non Operating Income (Expenses)
-11.24-15.36-13.67-12.8-10.13-8.99
Upgrade
EBT Excluding Unusual Items
-248.76-259.7-1,24810.84248.54299.15
Upgrade
Impairment of Goodwill
---1.78-1.78--
Upgrade
Gain (Loss) on Sale of Assets
-0.71-0.78-0-0.09-0.11-0.02
Upgrade
Asset Writedown
-1.3-1.3--0.27--
Upgrade
Other Unusual Items
6.14.718.499.4111.982.42
Upgrade
Pretax Income
-244.67-257.08-1,23218.12260.41301.56
Upgrade
Income Tax Expense
8.686.9516.467.9629.1550.42
Upgrade
Earnings From Continuing Operations
-253.35-264.03-1,24810.16231.26251.14
Upgrade
Minority Interest in Earnings
21.6814.557.947.362.311.7
Upgrade
Net Income
-231.66-249.48-1,24017.51233.57252.84
Upgrade
Net Income to Common
-231.66-249.48-1,24017.51233.57252.84
Upgrade
Net Income Growth
----92.50%-7.62%12.23%
Upgrade
Shares Outstanding (Basic)
940924919876934936
Upgrade
Shares Outstanding (Diluted)
940924919876934936
Upgrade
Shares Change (YoY)
1.14%0.58%4.91%-6.27%-0.23%-0.24%
Upgrade
EPS (Basic)
-0.25-0.27-1.350.020.250.27
Upgrade
EPS (Diluted)
-0.25-0.27-1.350.020.250.27
Upgrade
EPS Growth
----92.00%-7.41%12.50%
Upgrade
Free Cash Flow
-165.48-183.37-205.6-428.1-305.21-383.36
Upgrade
Free Cash Flow Per Share
-0.18-0.20-0.22-0.49-0.33-0.41
Upgrade
Dividend Per Share
---0.0050.026-
Upgrade
Dividend Growth
----80.77%--
Upgrade
Gross Margin
9.09%9.07%-22.88%43.71%58.01%68.55%
Upgrade
Operating Margin
-18.42%-17.34%-81.17%4.62%10.92%15.60%
Upgrade
Profit Margin
-24.27%-24.20%-87.93%0.75%7.87%10.70%
Upgrade
Free Cash Flow Margin
-17.34%-17.79%-14.58%-18.32%-10.28%-16.22%
Upgrade
EBITDA
-122.57-106.82-1,071164.93379.86424.06
Upgrade
EBITDA Margin
-12.84%-10.36%-75.90%7.06%12.80%17.94%
Upgrade
D&A For EBITDA
53.2971.9674.3956.9455.855.28
Upgrade
EBIT
-175.86-178.78-1,145107.99324.06368.78
Upgrade
EBIT Margin
-18.42%-17.34%-81.17%4.62%10.92%15.60%
Upgrade
Effective Tax Rate
---43.94%11.19%16.72%
Upgrade
Revenue as Reported
954.641,0311,4102,3362,9682,364
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.